Lung toxicity in a patient treated with sunitinib.

نویسندگان

  • Helen J Boyle
  • Gérard Chatté
  • Michel Rivoire
  • Aude Fléchon
چکیده

While pleural effusions are common, those secondary to pancreaticopleural fistulae are rare, most often occurring in patients with a history of chronic pancreatitis or alcoholism [1]. In this case the fistula formed from an IPMN. These are extremely rare entities that represent 10% of pancreatic cysts. They can show varying degrees of dysplasia with recurrence being rare in noninvasive types (,8%) versus invasive types (50–65%) [2]. Fistulae to abdominal viscera have been described previously [3]; however, to our knowledge, they have not been known to fistulate to the pleural cavity.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Sunitinib Induced Immune Thrombocytopenia

Sunitinib is an oral tyrosine kinase inhibitor which prevents tumor growth and metastatic progression. It was approved for treatment of advanced renal cell cancer, gastrointestinal stromal tumor and advanced pancreatic neuroendocrine tumors. It has several adverse reactions on multi organ systems including hematologic system. Although the neutropenia and thrombocytopenia commonly happens as Gra...

متن کامل

Sunitinib Induced Immune Thrombocytopenia

Sunitinib is an oral tyrosine kinase inhibitor which prevents tumor growth and metastatic progression. It was approved for treatment of advanced renal cell cancer, gastrointestinal stromal tumor and advanced pancreatic neuroendocrine tumors. It has several adverse reactions on multi organ systems including hematologic system. Although the neutropenia and thrombocytopenia commonly happens as Gra...

متن کامل

Sunitinib re-challenge in metastatic renal cell carcinoma treated sequentially with tyrosine kinase inhibitors and everolimus.

Therapy of patients with metastatic renal cell carcinoma (mRCC) requires sequential use of several agents with different mechanisms and minimal cross-resistance between the different agents. Tyrosine kinase inhibitors (TKIs) and mammalian target of rapamycin (mTOR) inhibitors prolong progression-free survival (PFS) in patients with mRCC. Re-challenge with TKIs provides clinical benefit after ev...

متن کامل

Aortic dissection in a patient treated by sunitinib for metastatic renal cell carcinoma.

The development of antiangiogenic agents targeting the vascular endothelial growth factor (VEGF) pathway (sunitinib, sorafenib, bevacizumab and temsirolimus) has revolutionized the treatment of metastatic renal clear-cell carcinoma. Adverse events attributed to these agents targeting the vascularization include cardiovascular effects. We report here a case of aortic dissection in a patient trea...

متن کامل

An Unusual Metastatic Renal Cell Carcinoma with Maintained Complete Response to Sunitinib Treatment

Recently, metastatic renal cell carcinoma (mRCC) treatment has changed dramatically with the onset of new therapies against molecular targets replacing immunotherapy as standard treatment. We report the case of a 49-year-old patient with a moderately differentiated renal clear cell carcinoma without extracapsular extension who underwent radical nephrectomy. Eight months after surgery, he develo...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • The European respiratory journal

دوره 40 5  شماره 

صفحات  -

تاریخ انتشار 2012